We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biotechnology Firms Push SEC to Expand Sarbanes-Oxley Exemptions
Biotechnology Firms Push SEC to Expand Sarbanes-Oxley Exemptions
March 17, 2006
The biotechnology sector is lobbying the SEC to adopt recommendations to exempt smaller companies from financial reporting and auditing requirements, alleging these standards create burdens that will stunt innovation.